Merriman Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,500
Closed -$226K 233
2021
Q4
$226K Buy
+1,500
New +$202K 0.02% 196
2020
Q4
Sell
-2,000
Closed -$227K 207
2020
Q3
$227K Buy
+2,000
New +$210K 0.03% 151

Other funds holding TNDM

Merriman Wealth Management's TNDM Position: Q1 2022 in Review

Merriman Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 1,500 shares — an estimated $226K sold.

Merriman Wealth Management first reported a position in TNDM in Q3 2020 and held it in 2 quarters. The position peaked at $227K in Q3 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Merriman Wealth Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Merriman Wealth Management sold 1,500 Tandem Diabetes Care shares in Q1 2022, an estimated $226K.
  • Merriman Wealth Management first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 2 quarters.
  • Merriman Wealth Management's Tandem Diabetes Care position peaked at $227K in Q3 2020.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Merriman Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.